Trial
NCT00581477
Treatment of Orthostatic Hypotension
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Autonomic Nervous System Diseases
Intervention
Droxidopa Oral Product
Why stopped
1\. enrollment slower than anticipated; 2. FDA approval of droxidopa so no longer need to treat patients on research basis; 3. personnel who were primarily responsible for the study are no longer at Vanderbilt.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-02